The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for R De Francesco


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase.EBI
P. Angeletti S.P.A. (Merck Research Laboratories)
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.EBI
Istituto Di Ricerche Di Biologia Molecolare
A series of novel, potent, and selective histone deacetylase inhibitors.EBI
Irbm/Merck Research Laboratories
Mechanism of hepatitis C virus RNA polymerase inhibition with dihydroxypyrimidines.EBI
Mcgill University
Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors.EBI
Istituto Di Ricerche Di Biologia Molecolare &Quot;P. Angeletti
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies.EBI
Irbm (Merck Research Laboratories Rome)
2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis.EBI
P. Angeletti S.P.A. (Merck Research Laboratories)
Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase.EBI
Irbm (Merck Research Laboratories Rome)
Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase.EBI
Irbm (Merck Research Laboratories Rome)
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators.EBI
Promidis
HCV NS5b RNA-dependent RNA polymerase inhibitors: from alpha,gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis.EBI
Italy. Vinc
The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase.EBI
Mrl Rome
Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase.EBI
Italy. Vinc
Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: discovery, initial SAR, and molecular modeling.EBI
Mrl Rome
A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease.EBI
Irbm, Mrl Rome
Substituted triazoles useful as Axl inhibitorsBDB
Rigel Pharmaceuticals
1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.BDB
Nerviano Medical Sciences
Potent and selective nonpeptide inhibitors of caspases 3 and 7.BDB
Glaxosmithkline